Conference · Baltimore, Maryland
Immunogenicity for Biotherapeutics 2012
Biotechnology · Science
Key numbers
- Editions on record
- 5first in 2009
About Immunogenicity for Biotherapeutics
This year's program was a tremendous success, and we're getting ready to make next year's show even better! Keep watching this space for upcoming updates about the 13th-annual Immunogenicity for Biotherapeutics conference.
12 Reasons to Attend the 12th Annual
Immunogenicity Event
-10 Poster Sessions to Expand Scientific Discussions
-5 Perspectives Comparing FDA and EMEA Guidelines
-4 Panel Discussions Revealing Industry Tools to Reduce Immunogenicity
-7 Countries Represented for Global Regulatory and Pharmaceutical Perspectives
-4 New Technology Comparison Case Studies
-10 Round Table Subject Matter Expert Opportunities
-3 Hour workshop on Strategies for Immunogenicity Assessment of Biosimilars
-30 Biopharmaceutical Companies Represented
-3 Hours Dedicated to the Fundamentals of Immunogenicity Studies
-5 Approaches for Accurately Predicting Immunogenicity
-6 White Paper Authors Provide Clear Recommendations
-40 Industry Experts Share Best Practices for Immunogenicity Studies
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2014 | 17–20 Mar 2014 | Baltimore Marriott Inner Harbor at Camden Yards Baltimore, Maryland | — | — |
| 2013 | 18–20 Mar 2013 | Baltimore Marriott Inner Harbor at Camden Yards Baltimore, Maryland | — | — |
| 2012 | 17–19 Apr 2012 | Hyatt Regency Baltimore Baltimore, Maryland | — | — |
| 2011 | 4–6 Apr 2011 | L'Enfant Plaza Hotel Washington, District of Columbia | — | — |
| 2010 | 3–5 May 2010 | Palace Hotel San Francisco, California | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.